Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 18/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 14/20 | 0.50 |
| ▸ | TSHR | P16473 | 7/20 | 0.50 |
| ▸ | CLK4 | Q9HAZ1 | 4/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 9/20 | 0.48 |
| ▸ | USP2 | O75604 | 9/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 12/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 8/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | CASP1 | P29466 | 1/20 | 0.46 |
| ▸ | CASP7 | P55210 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | CDK9 | P50750 | 1/20 | 0.36 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23346841 | 0.78 | CYP1A2 (0.49) | CYP1A2CYP3A4TSHRCLK4HSD17B10 | |
| SCHEMBL19055938 | 0.78 | CYP1A2 (0.46) | CYP1A2CYP3A4TSHRCLK4HSD17B10 | |
| SCHEMBL28194814 | 0.78 | CYP1A2 (0.43) | CYP1A2CYP3A4TSHRCLK4HSD17B10 | |
| SCHEMBL14879948 | 0.78 | CYP1A2 (0.49) | CYP1A2CYP3A4TSHRCLK4HSD17B10 | |
| SCHEMBL21927511 | 0.76 | CDK5 (0.45) | CYP1A2CYP3A4TSHRCLK4HSD17B10 | |
| SCHEMBL21925844 | 0.76 | CYP1A2 (0.48) | CYP1A2CYP3A4TSHRCLK4HSD17B10 | |
| SCHEMBL19428747 | 0.76 | CYP1A2 (0.41) | CYP1A2CYP3A4TSHRCLK4HSD17B10 | |
| SCHEMBL11916063 | 0.76 | CYP1A2 (0.47) | CYP1A2CYP3A4TSHRCLK4HSD17B10 | |
| SCHEMBL11946715 | 0.76 | CYP1A2 (0.47) | CYP1A2CYP3A4TSHRCLK4HSD17B10 | |
| SCHEMBL9690911 | 0.75 | CYP1A2 (0.48) | CYP1A2CYP3A4TSHRCLK4HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3873484-B1 | NOVEL STING AGONISTS | VENENUM BIODESIGN LLC (US) | 2023-08-23 | — | — | EP | disclosed |
| WO-2021110890-A1 | PYRIDINIUM DERIVATIVES AS HERBICIDES | SYNGENTA CROP PROTECTION AG (CH) | 2021-06-10 | — | — | WO | disclosed |
| US-10760116-B2 | Analysis kit, analyzer, and methods for analyzing template nucleic acid or target substance | KABUSHIKI KAISHA DNAFORM (JP) | 2020-09-01 | — | — | US | disclosed |
| EP-3339447-B1 | METHOD FOR ANALYZING TEMPLATE NUCLEIC ACID, METHOD FOR ANALYZING TARGET SUBSTANCE, ANALYSIS KIT FOR TEMPLATE NUCLEIC ACID OR TARGET SUBSTANCE, AND ANALYZER FOR TEMPLATE NUCLEIC ACID OR TARGET SUBSTANCE | DNAFORM KK (JP) | 2020-07-29 | — | — | EP | disclosed |
| EP-3401407-B1 | NUCLEIC ACID PROBE, METHOD FOR DESIGNING NUCLEIC ACID PROBE, AND METHOD FOR DETECTING TARGET SEQUENCE | DNAFORM KK (JP) | 2020-04-22 | — | — | EP | disclosed |
| US-10428371-B2 | Fluorescent labeled single-stranded nucleic acid and use thereof | KABUSHIKI KAISHA DNAFORM (JP) | 2019-10-01 | — | — | US | disclosed |
| US-20190032108-A1 | METHOD FOR ANALYZING TEMPLATE NUCLEIC ACID, METHOD FOR ANALYZING TARGET SUBSTANCE, ANALYSIS KIT FOR TEMPLATE NUCLEIC ACID OR TARGET SUBSTANCE, AND ANALYZER FOR TEMPLATE NUCLEIC ACID OR TARGET SUBSTANCE | RIKEN (JP) | 2019-01-31 | — | — | US | disclosed |
| EP-2891714-B1 | METHOD FOR ANALYZING TARGET NUCLEIC ACID, KIT, AND ANALYZER | DNAFORM KK (JP) | 2018-07-11 | — | — | EP | disclosed |
| EP-3339447-A1 | METHOD FOR ANALYZING TEMPLATE NUCLEIC ACID, METHOD FOR ANALYZING TARGET MATERIAL, KIT FOR ANALYZING TEMPLATE NUCLEIC ACID OR TARGET MATERIAL, AND DEVICE FOR ANALYZING TEMPLATE NUCLEIC ACID OR TARGET MATERIAL | Kabushiki Kaisha DNAFORM (JP) | 2018-06-27 | — | — | EP | disclosed |
| US-9862989-B2 | Nucleic acid probe, method for designing nucleic acid probe, and method for detecting target sequence | KABUSHIKI KAISHA DNAFORM (JP) | 2018-01-09 | — | — | US | disclosed |
| US-20080306275-A1 | NOVEL HETEROARYL DERIVATIVE | DANIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2008-12-11 | — | — | US | disclosed |
| US-20080227104-A1 | Replication; hybridization; kits | RIKEN (JP) | 2008-09-18 | — | — | US | disclosed |
| US-20080227104-A1 | Replication; hybridization; kits | RIKEN (JP) | 2008-09-18 | — | — | US | disclosed |
| EP-1970453-A2 | Primer, primer set, and nucleic acid amplification method and mutation detection method using the same | Riken (JP) | 2008-09-17 | — | — | EP | disclosed |
| US-7425642-B2 | Heteroaryl derivative | DAINIPPON SUMITOMO PHARMA CO. ,LTD. (JP) | 2008-09-16 | — | — | US | disclosed |
| US-7425642-B2 | Heteroaryl derivative | DAINIPPON SUMITOMO PHARMA CO. ,LTD. (JP) | 2008-09-16 | — | — | US | disclosed |
| US-20080167306-A1 | Novel Heteroaryl Derivative | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2008-07-10 | — | — | US | disclosed |
| US-20080167306-A1 | Novel Heteroaryl Derivative | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2008-07-10 | — | — | US | disclosed |
| US-20080119466-A1 | Heteroarylphenylurea Derivative | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2008-05-22 | — | — | US | disclosed |
| EP-1837329-A1 | NOVEL HETEROARYL DERIVATIVE | Dainippon Sumitomo Pharma Co., Ltd. (JP) | 2007-09-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080167306-A1 | Novel Heteroaryl Derivative | GPR119, SLC2A4, SLC5A2 | CYP1A2 186/4885CYP3A4 252/4885TSHR 1325/4885 |
| US-20080227104-A1 | Replication; hybridization; kits | PCNA, POLL, RNGTT | CYP1A2 4851/4885CYP3A4 4220/4885TSHR 2406/4885 |
| US-20080306275-A1 | NOVEL HETEROARYL DERIVATIVE | NR0B1, UGT1A10, NR0B2 | CYP1A2 30/4885CYP3A4 21/4885TSHR 1748/4885 |
| US-20080119466-A1 | Heteroarylphenylurea Derivative | CHRM1, CBR3, CHRM2 | CYP1A2 15/4885CYP3A4 31/4885TSHR 154/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.